onxeo
  • English
  • Français
>>>>
    • News
    • Agenda
    • Subscribe to news

Get to know AsiDNA

View corporate presentation

BECOME A PARTNER
BECOME A SHAREHOLDER

NEWS >

Onxeo to host a Conference Call today to comment on the main findings from ReLive Phase III Study of Livatag®

Onxeo Grants Exclusive Worldwide License of Validive® developed for the treatment of oral severe mucositis to Monopar Therapeutics

AGENDA >

French Society of Financial Analysts meeting: Strategic Portfolio & Newsflow Update

October 2nd, 2017

back up ↑
  • Terms of use
  • Contact
© Copyright 2017 onxeo | The sections “The group”, “Our products”, “Partnerships”, “Investors”, “Media” are dedicated to investors. | Webdesign : Limbus Studio